ZOLL Itamar

Itamar Medical is a publicly-traded medical device company (NASDAQ&TASE: ITMR) that develops and markets innovative diagnostic and therapy solutions for sleep apnea disorders and cardiovascular conditions. WatchPAT, the company's FDA-approved flagship product is used for diagnosing sleep apnea in the home environment. WatchPAT is an easy-to-use patient-led alternative with unique abilities to interpret test results automatically, as well as produce a full sleep report. The WatchPAT is sold today both as a stand-alone device and, more importantly, as part of a complete solution (TSS) to further aid the diagnosis and treatment for Sleep Apnea patients that suffer from related comorbidities, such as cardiac diseases. Itamar Medical is focused on leading the integration of Sleep Apnea Management into the Cardiac patient care pathway with Total Sleep Solutions (TSS): Through collaboration with leading sleep physicians and industry partners, Itamar Medical has pioneered a novel cross-disciplinary model of care. TSS expands the reach of sleep services by enabling point of care variability, providing a scalable model for management of a massive volume of patients' while reducing wait times and overall cost, and offering optimized IT systems and human field resources to support the vast underdiagnosed pool of cardiac patients suffering from the co-morbidity of Sleep Apnea. • Simplifying patient access to Sleep Apnea care • Improving patient flow management • Optimizing therapy and patient compliance Partnerships: During the past few years, Itamar Medical has signed a number of strategic marketing agreements for its products, including agreements with Medtronic, Philips, Resmed, SoClean and BetterNight in the US, and Philips Respironics and in Japan. All posted materials are subject to a disclaimer available here: https://bit.ly/3dZfGPU Hashtags: #sleep #cardiology #digitalhealth #medtech #telehealth #watchpat #telesa